BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7878035)

  • 21. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
    Anisowicz A; Sotiropoulou G; Sager R
    Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells.
    Cavaillès V; Augereau P; Rochefort H
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):203-7. PubMed ID: 8419924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human gene for the regulatory subunit RI alpha of cyclic adenosine 3', 5'-monophosphate-dependent protein kinase: two distinct promoters provide differential regulation of alternately spliced messenger ribonucleic acids.
    Solberg R; Sandberg M; Natarajan V; Torjesen PA; Hansson V; Jahnsen T; Taskén K
    Endocrinology; 1997 Jan; 138(1):169-81. PubMed ID: 8977401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transcriptional start site for a human U6 small nuclear RNA gene is dictated by a compound promoter element consisting of the PSE and the TATA box.
    Goomer RS; Kunkel GR
    Nucleic Acids Res; 1992 Sep; 20(18):4903-12. PubMed ID: 1408805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of a GC-rich promoter of the human parathyroid hormone-related peptide gene.
    Vasavada RC; Wysolmerski JJ; Broadus AE; Philbrick WM
    Mol Endocrinol; 1993 Feb; 7(2):273-82. PubMed ID: 8469240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immediate upstream promoter regions required for neurospecific expression of SNAP-25.
    Ryabinin AE; Sato TN; Morris PJ; Latchman DS; Wilson MC
    J Mol Neurosci; 1995; 6(3):201-10. PubMed ID: 8672402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.
    Warnecke C; Willich T; Holzmeister J; Bottari SP; Fleck E; Regitz-Zagrosek V
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):17-24. PubMed ID: 10229654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal cell type-specific promoter of the alpha CaM kinase II gene is activated by Zic2, a Zic family zinc finger protein.
    Sakurada T; Mima K; Kurisaki A; Sugino H; Yamauchi T
    Neurosci Res; 2005 Nov; 53(3):323-30. PubMed ID: 16157407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P3 promoter element of bovine papillomavirus.
    Rho J; Park SD; Choe J
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):205-11. PubMed ID: 8390322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The new core promoter element XCPE1 (X Core Promoter Element 1) directs activator-, mediator-, and TATA-binding protein-dependent but TFIID-independent RNA polymerase II transcription from TATA-less promoters.
    Tokusumi Y; Ma Y; Song X; Jacobson RH; Takada S
    Mol Cell Biol; 2007 Mar; 27(5):1844-58. PubMed ID: 17210644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a cis-acting dendritic targeting element in the mRNA encoding the alpha subunit of Ca2+/calmodulin-dependent protein kinase II.
    Blichenberg A; Rehbein M; Müller R; Garner CC; Richter D; Kindler S
    Eur J Neurosci; 2001 May; 13(10):1881-8. PubMed ID: 11403681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of the GC-rich and cyclic adenosine 3',5'-monophosphate (cAMP)-inducible promoter of the type II beta cAMP-dependent protein kinase regulatory subunit gene.
    Kurten RC; Levy LO; Shey J; Durica JM; Richards JS
    Mol Endocrinol; 1992 Apr; 6(4):536-50. PubMed ID: 1316546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of an archaebacterial promoter: essential role of a TATA box for transcription efficiency and start-site selection in vitro.
    Reiter WD; Hüdepohl U; Zillig W
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9509-13. PubMed ID: 2124695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction of an initiator element in the mouse thymidylate synthase promoter alters S phase regulation but has no effect on promoter bidirectionality.
    Kapadia F; Johnson LF
    J Cell Biochem; 2006 Feb; 97(3):599-608. PubMed ID: 16215980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.
    Osaki M; Tan L; Choy BK; Yoshida Y; Cheah KS; Auron PE; Goldring MB
    Biochem J; 2003 Jan; 369(Pt 1):103-15. PubMed ID: 12223098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of tissue-specific transcription by the human synapsin I gene promoter.
    Thiel G; Greengard P; Südhof TC
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3431-5. PubMed ID: 1849657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of an enhancer and an alternative promoter in the first intron of the alpha-fetoprotein gene.
    Scohy S; Gabant P; Szpirer C; Szpirer J
    Nucleic Acids Res; 2000 Oct; 28(19):3743-51. PubMed ID: 11000266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organization and analysis of the complete rat calmodulin-dependent protein kinase IV gene.
    Sun Z; Means RL; LeMagueresse B; Means AR
    J Biol Chem; 1995 Dec; 270(49):29507-14. PubMed ID: 7493991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional regulation of the human choline acetyltransferase gene.
    Hersh LB; Inoue H; Li YP
    Prog Brain Res; 1996; 109():47-54. PubMed ID: 9009692
    [No Abstract]   [Full Text] [Related]  

  • 40. Functional implications of CaMKII alternative splicing.
    Sloutsky R; Stratton MM
    Eur J Neurosci; 2021 Oct; 54(8):6780-6794. PubMed ID: 32343011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.